Brain permeable zinc complex with neuroprotective action;Complexe de zinc a action neuroprotectrice diffusible au niveau du cerveau

S.T.P. Pharma Sciences

Volumn 7, Issue 1, 1997, Pages 92-97

  Saji, H ^a   Kinoshita, T ^a   Kubota, M ^a   Kaneda, K ^a   Akaike, A ^a   Kikuchi, M ^a   Kashii, S ^a   Honda, Y ^a   Iida, Y ^a   Magata, Y ^a   Yokoyama, A ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biodistribution; Bisthiosemicarbazone; Brain; Glutamate Neurotoxicity; Ischemia; N methyl D aspartate receptor; Receptor binding assay; Retina; Zinc complex

Indexed keywords

2,3 BUTANEDIONE BIS(N4 DIMETHYLTHIOSEMICARBAZONE) ZINC COMPLEX; BIS(THIOSEMICARBAZONE); GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INTRACELLULAR TRANSPORT; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RETINA NERVE CELL;

EID: 0031544661     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ROTHMAN P.R. and OLNEY J.W. - Glutamate and the patholophysiology of hypoxic-ischaemic brain damage. - Ann. Neurol., 19, 105-111, 1986.
2. CHOI D.W. and ROTHMAN S.M. - The role of glutamate neurotoxicity in hypoxic-ischaemic neuronal death. - Ann. Rev. Neurosci., 13, 171-182, 1990.
3. DAVID P., LUSKY M. and TEICHBERG V.I. - Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. - Exp. Eye Res., 46, 657-662, 1988.
4. AKAIKE A., TAMURA Y., SATOY. et al. - Cholecystocystokinin induced protection of cultured cortical neurons against glutamate neurotoxicity. - Brain Res., 557, 303-307, 1991.
5. KASHII X., TAKAHASHI M., MANDAI M. et al. - Protective action of dopamine against glutamate neurotoxicity in the retina. - Invest. Ophthalmol. Vis. Sci., 35, 685-695, 1994.
6. KIKUCHI M., KASHII S., HONDA Y., UJIHARA H., SASA M., TAMURA Y. and AKAIKE A. - Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons. - Invest. Ophthalmol. Vis. Sci., 36, 2048-2053, 1995.
7. PARK C.K., NEHLS D.G., GRAHAM D.I., TEASDALE G.M. and McCULLOCH J. - The glutamate antagonist MK-801 reduces focal ischaemic brain damage in the rat. - Ann. Neurol., 24, 543-551, 1988.
8. OZYURT E., GRAHAM D.I., WOODRUFF G.N. and McCULLOCH J. - Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischaemia in the cat. - J. Cereb. Blood Flow Metab., 8, 138-143, 1988.
9. PARK C.K., NEHLS D.G., GRAHAM D.I., TEASDALE G.M. and McCULLOCH J. - Focal cerebral ischaemia in the cat. Treatment with the glutamate antagonist MK-801 after induction of ischaemia. - J. Cereb. Blood Flow Metab., 8, 757-762, 1988.
10. ABU EL-ASTAR A.M., MORSE P.H., MAIMONE D., TORCZYNSKI E. and REDER A.T. - MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. - Invest. Ophthalmol. Vis. Sci., 33, 3463-3468, 1992.
11. DIETRICH W.D., LIN B., GLOBUS M.Y.T., GREEN E.J., GINSBERG M.D. and BUSTO R. - Effect of delayed MK-801 (dizocilpine) treatment with or without immediate post-ischaemic hypothermia on chronic neuronal survival after global forebrain ischaemia in rats. - J. Cereb. Blood Flow Metab., 15, 960-968, 1995.
12. OLNEY J.W., LABRUYERE J., WANG G. et al. - NMDA antagonist neurotoxicity : mechanism and prevention. - Science, 254, 1518, 1991.
13. REYNOLDS I.J. and MILLER R.J. - Multiple sites for the regulation of the N-methyl-D-aspartate receptor. - Mol. Pharmacol., 33, 581-584, 1988.
14. 3H]MK801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations : evidence for multiple regulatory sites. - Eur. J. Pharmacol., 151, 103-112, 1988.
15. 2+ : an endogenous modulator of ligand and voltage gated ion channels. - Neuropharmacology, 33, 935-952, 1994.
16. SMART T.G., XIE X. and KRISHEK B. - Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. - Prog. Neurobiol., 42, 393-441, 1994.
17. UJIHARA H., AKAIKE A., TAMURA Y. et al. - Blockage of retinal NMDA receptors by sodium nitro prusside is probably due to nitric oxide formation. - Jpn. J. Pharmacol., 61, 375-377, 1993.
18. FOX M.R.S. - Zinc excess. - In : Zinc in Human Biology, C.F. Muills Ed., Springer Verlag, London, 1989, pp. 365-370.
19. TAKEDA A., AKIYAMA T., SAWASHITA J. and OKADA S. - Brain uptake of trace metals, zinc and manganese in rats. - Brain Res., 640, 341-344, 1994.
20. GINGRAS B.A., SUPRUNCHUK T. and BAYLEY C.H. - The preparation of some thiosemicarbazones and their copper complexes. - Can. J. Chem., 40, 1053-1059, 1962.
21. PETERING D.H. - Concerning the role of zinc in the antitumour activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) zinc(II) and related chelates. - Biochem. Pharmacol., 23, 567-576, 1974.
22. GREEN M.A., KIPPENSTEIN D.L. and TENNISON J.R. - Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. - J. Nucl. Med., 29, 1549-1557, 1988.
23. JOHN E.K. and GREEN M.A. - Structure-activity relationships for metal labeled blood flow tracers : comparison of keto aldehyde bis(thisemocarbazonato)copper(II) derivatives. - J. Med. Chem., 33, 1764-1770, 1990.
24. SAJI H., SAIGA A., IIDA Y., MAGATA Y. and YOKOYAMA A. - Synthesis and in vivo behaviour of a copper-64-labelled dithiosemicarbazone derivative coupled to a dihydropyridine carrier. - J. Label. Comp. Radiopharm., 33, 127-135, 1993.
25. 62Cu-PTSM. - Nucl. Med. Biol., 19, 39-44, 1992.
26. WADA K., FUJIBAYASHI Y. and YOKOYAMA A. - Copper(II) [2,3-butanedionebis(N4-methylthiosemicarbazone)], a stable superoxide dismutase-like coppercomplex with high membrane penetrability. - Arch. Biochem. Biophys., 310, 1-5, 1994.
27. 2 receptor studies : effects of lipophilicity and receptor affinity on the in vivo biodistribution. - Chem. Pharma. Bull., 40, 165-169, 1992.
28. LOWRY O.H., ROSEBROUGH N.J., FARR A.L. and RANDALL R.J. - Protein measurement with the Folin phenol reagent. - J. Biol. Chem., 193, 265-275, 1951.
29. OLDENDORF W.H. - Lipid solubility and drug penetration of the blood-brain barrier. - Proc. Soc. Exp. Biol. Med., 147, 813-816, 1974.
30. DISCHINO D.D., WELCH M.J., KILBOURN M. and RAICHLE M.E. - Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. - J. Nucl. Med., 24, 1030-1038, 1983.
31. KARCIOGLU Z.A. - Zinc in the eye. - Surv. Ophthalmol., 27, 114-122, 1982.